Effects of Natural Health Products in Combination with FP-Based Chemotherapy.

Pharmaceuticals (Basel) · 2025 · PMC12655697 · PMID 41305008

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

reported that patients with stage III CRC undergoing adjuvant therapy with FPs combined with PRM1201 showed a lower incidence of grade 3 or 4 neutropenia, although this did not reach statistical significance [ 32 ].

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.